At the time of writing, Biohaven Ltd [BHVN] stock is trading at $16.07, down -0.86%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BHVN shares have gain 3.01% over the last week, with a monthly amount glided 5.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biohaven Ltd [NYSE: BHVN] stock has seen the most recent analyst activity on September 03, 2025, when Raymond James initiated its Strong Buy rating and assigned the stock a price target of $75. Previously, RBC Capital Mkts downgraded its rating to Sector Perform on May 19, 2025, and kept the price target unchanged to $21. On February 11, 2025, Deutsche Bank initiated with a Buy rating and assigned a price target of $65 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $57 on September 16, 2024. Bernstein initiated its recommendation with a Outperform and recommended $55 as its price target on September 04, 2024. Morgan Stanley started tracking with a Overweight rating for this stock on July 24, 2024, and assigned it a price target of $58. In a note dated February 16, 2024, RBC Capital Mkts initiated an Outperform rating and provided a target price of $62 on this stock.
For the past year, the stock price of Biohaven Ltd fluctuated between $12.79 and $55.70. Currently, Wall Street analysts expect the stock to reach $60 within the next 12 months. Biohaven Ltd [NYSE: BHVN] shares were valued at $16.07 at the most recent close of the market. An investor can expect a potential return of 273.37% based on the average BHVN price forecast.
Analyzing the BHVN fundamentals
Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -208.91%, Pretax Profit Margin comes in at -199.72%, and Net Profit Margin reading is -199.94%. To continue investigating profitability, this company’s Return on Assets is posted at -1.39, Equity is -2.71 and Total Capital is -1.88. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.75 points at the first support level, and at 15.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 16.33, and for the 2nd resistance point, it is at 16.59.
Ratios To Look Out For
It is important to note that Biohaven Ltd [NYSE:BHVN] has a current ratio of 3.82. As well, the Quick Ratio is 3.82, while the Cash Ratio is 1.33.
Transactions by insiders
Recent insider trading involved CHILDS JOHN W, Director, that happened on Mar 04 ’25 when 32700.0 shares were purchased. Director, CHILDS JOHN W completed a deal on Dec 30 ’24 to buy 29000.0 shares. Meanwhile, Director CHILDS JOHN W bought 21052.0 shares on Oct 02 ’24.
